hypogonadism

* Randomized trials in obese hypogonadal men showed benefits including increased muscle mass, reduced fat, higher HDL, improved erectile function, and elevated TT. Older age (>55 years) was linked to reduced androgenic response. In late-onset hypogonadism, CC discontinuation led to relapse...

Important case study! Listen closely 10:40-40:35 * if you want to have a hard on you need ESTRADIOL! KEY POINTS * aromatase and estradiol are important for men's health * estradiol is an ESSENTIAL METABOLITE of T * I show you on this slide that most of the beneficial actions of...

Dr Khera speaks about an important subject.

Abstract Introduction Testosterone deficiency (TD) may occur after radical prostatectomy (RP). Guidance on prevalence, mechanisms, and testosterone-replacement therapy (TRT) safety remains limited. Objective To summarize contemporary evidence on the etiology of post-RP TD. Methods A...

* Within the arcuate nucleus, a specialized subset of kisspeptin neurons, known as KNDy (Kisspeptin/Neurokinin B/Dynorphin) cells, functions as a “pulse generator,” coordinating rhythmic bursts of activity that drive the pulsatile release of GnRH [3, 4]. * Three healthy adult men received a...

36:01 Long-term TRT and receptor sensitivity concerns 42:30 Androgen receptors and long-term adaptation KYZATREX: UNIQUE LYMPHATIC ABSORPTION Testosterone isn’t just about libido. It’s one of the most important metabolic signals in the body, yet most people never test it, and most...

In this insightful presentation, Dr. Leon Telis examines the evolving evidence behind testosterone replacement therapy (TRT) in men with prostate cancer. Once considered unsafe, TRT is now supported by growing research showing that it can be both safe and beneficial for select patients...

Hey everyone, looking for informed opinions/experiences because I’ve been dealing with this for a while now. Background: 21 years old male Only one testicle (lost the other earlier, long story involving medical negligence which has honestly made me very skeptical of doctors) Remaining...

Dr. Corona another powerhouse in the field! * The current video summarizes and critical analyzes available evidence from the first reports to a recently updated meta-analysis [1]. Data derived from a meta-analytic approach, including 25 studies and 18,237 subjects showed that MetS was...

* Over the course of his career, he has earned international recognition as a pioneer in the diagnosis and treatment of male sexual dysfunction and has mentored generations of urologists who continue to shape the field today...

Sit and dwell on that! Think of all those overmedicated men on T-therapy gassed up on FT well beyond their natty genetic set-point and unfortunately many off them off the hop! You can blame all those run of the mill T clinics, kiddie forums loaded with all those numbskulls, throw those blast n...

In this powerful episode of Fertility Fact or Fiction, Dr. Victory sits down with urologist and men’s health expert Dr. Justin Houman to break down one of the most misunderstood topics in reproductive health: erectile dysfunction and male infertility. Is erectile dysfunction just a...

Again where is that natty male FT 30-60 ng/dL and we are talking a daily short-lived peak here LMFAO! Healthy men 18 to 29 years old hitting a high peak FT 25.3 ng/dL are those outliers that fall in the 97.5th percentile! Better yet look at where the median FT 12 ng/dL sits LOL...

Bright future! Big things coming soon! Yuvna Jain, a Biological Systems Engineering student at Plaksha University, is currently a research intern at Brigham and Women’s Hospital, Harvard Medical School, Boston, through the Khorana Scholars Program. Working in the lab of Dr. Shailendra...

• The shift from injections to oral testosterone solutions In this episode, Luke sits down with Shalin Shah, CEO of Marius Pharmaceuticals, to unpack the truth about testosterone. They explore the science, debunk common myths, and discuss innovative solutions designed to make hormone...

Panelists: Dr. Abraham Morgentaler Dr. Mohit Khera Dr. Martin Miner

In this episode of Fertility and Other F Words, Dr. Amy Pearlman and Dr. Larry Lipshultz sit down with Mohit Khera for a candid, practical discussion on testosterone and erectile function. Dr. Khera is a board-certified urologist at Baylor College of Medicine, where he holds the F. Brantley...

Stop wasting your time on those kiddie forums, Nelson's house is where it's at! Dr. Omer Raheem Agenda Conclusions

In this SCCR Science Series session, Elaine Costa, MD, a postdoctoral scholar in the Department of Otolaryngology, Head, and Neck Surgery (OHNS) provides an overview of obstructive sleep apnea (OSA). Here she covers:

* Enclomiphene is one of two stereoisomers of clomiphene, the other being Zuclomiphene. Whilst zuclomiphene is more oestrogenic, enclomiphene is more anti-oestrogenic. Zuclomiphene is generally antigonadotropic due to its effects on oestrogen receptors, which leads to a subsequent reduction in...

Great presentation by the leading expert in the field! Abraham Morgentaler For 80 years the question has been: Wrong question The right question: Conclusions

Reframing risk

Professor Alan Rogol

Professor Michael Zitzmann Testosterone Deficiency (TD). and its Effects https://www.excelmale.com/threads/the-male-hormone-reset-how-glp-1ras-lifestyle-and-testosterone-transform-obesity-linked-problems.33386/

Are men going through their own version of menopause? In this episode of MAN ALIVE, NHS GP and leading men's health specialist Dr Jeff Foster breaks down everything you need to know about testosterone: what it is, why levels are falling, how it affects mood, sex drive, strength, motivation and...

How often should men on TRT check their hematocrit? The standard monitoring schedule includes a baseline CBC before starting TRT, a recheck at 3 to 6 weeks, another at 3 months, and then at 6 and 12 months once stable. Any dose or formulation change resets the monitoring clock, requiring a...

Hitting the nail on the head here! * More than 30 years later, he argues that the regulatory framework no longer reflects current clinical evidence and may be doing more harm than good. In this episode, Arundhati Parmar interviews Shalin Shah, CEO of Marius Pharmaceuticals, about...

DEBATE: WHAT IS A LOW TESTOSTERONE? Professor Geoffrey Hackett Professor Shalender Bhasin Synthesis

Dr. Janine Davis Overview Conclusion

Synthesis and Conclusions

Dr, Channa Jayasena